CN1066068A - 4-芳基-3-(芳香杂环基脲基)喹啉类衍生物 - Google Patents

4-芳基-3-(芳香杂环基脲基)喹啉类衍生物 Download PDF

Info

Publication number
CN1066068A
CN1066068A CN92103010A CN92103010A CN1066068A CN 1066068 A CN1066068 A CN 1066068A CN 92103010 A CN92103010 A CN 92103010A CN 92103010 A CN92103010 A CN 92103010A CN 1066068 A CN1066068 A CN 1066068A
Authority
CN
China
Prior art keywords
quinoline
chloro
phenyl
group
urea groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN92103010A
Other languages
English (en)
Chinese (zh)
Inventor
E·S·滨中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1066068A publication Critical patent/CN1066068A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
CN92103010A 1991-04-26 1992-04-25 4-芳基-3-(芳香杂环基脲基)喹啉类衍生物 Pending CN1066068A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69232391A 1991-04-26 1991-04-26
US692,323 1991-04-26

Publications (1)

Publication Number Publication Date
CN1066068A true CN1066068A (zh) 1992-11-11

Family

ID=24780107

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92103010A Pending CN1066068A (zh) 1991-04-26 1992-04-25 4-芳基-3-(芳香杂环基脲基)喹啉类衍生物

Country Status (20)

Country Link
EP (1) EP0590094A1 (enExample)
JP (1) JPH0776215B2 (enExample)
CN (1) CN1066068A (enExample)
AU (1) AU1879792A (enExample)
BR (1) BR9205939A (enExample)
CA (1) CA2108014A1 (enExample)
CZ (1) CZ395592A3 (enExample)
DE (1) DE9290049U1 (enExample)
FI (1) FI934710A0 (enExample)
HU (1) HUT65748A (enExample)
IE (1) IE921330A1 (enExample)
IL (1) IL101627A0 (enExample)
MX (1) MX9201916A (enExample)
NO (1) NO933837L (enExample)
NZ (1) NZ242493A (enExample)
PT (1) PT100426A (enExample)
TW (1) TW197436B (enExample)
WO (1) WO1992019614A1 (enExample)
YU (1) YU44592A (enExample)
ZA (1) ZA922976B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103601677A (zh) * 2013-11-19 2014-02-26 清华大学 制备2-烷硫基喹啉衍生物的方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015058A1 (en) * 1992-01-23 1993-08-05 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
AU699091B2 (en) * 1995-05-31 1998-11-19 Dainippon Sumitomo Pharma Co., Ltd. Novel naphthyridine derivatives
WO1998023615A1 (en) * 1996-11-26 1998-06-04 Sumitomo Pharmaceuticals Company, Limited Novel naphthyridine derivatives
AU2547399A (en) 1998-02-25 1999-09-15 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for producing the same
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
SV2005001973A (es) * 2003-12-12 2005-11-04 Wyeth Corp Quinolinas utiles en el tratamiento de enfermedades cardiovasculares ref. wyth0090-504 (am101500)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
TW205037B (enExample) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103601677A (zh) * 2013-11-19 2014-02-26 清华大学 制备2-烷硫基喹啉衍生物的方法
CN103601677B (zh) * 2013-11-19 2015-11-18 清华大学 制备2-烷硫基喹啉衍生物的方法

Also Published As

Publication number Publication date
ZA922976B (en) 1993-10-25
YU44592A (sh) 1994-12-28
CA2108014A1 (en) 1992-10-27
PT100426A (pt) 1993-08-31
IE921330A1 (en) 1992-11-04
DE9290049U1 (de) 1994-01-05
AU1879792A (en) 1992-12-21
JPH0776215B2 (ja) 1995-08-16
MX9201916A (es) 1992-11-01
FI934710L (fi) 1993-10-25
CZ395592A3 (en) 1994-02-16
EP0590094A1 (en) 1994-04-06
WO1992019614A1 (en) 1992-11-12
NZ242493A (en) 1994-08-26
JPH06501025A (ja) 1994-01-27
NO933837L (no) 1993-10-25
IL101627A0 (en) 1992-12-30
HUT65748A (en) 1994-07-28
FI934710A7 (fi) 1993-10-25
BR9205939A (pt) 1994-09-27
FI934710A0 (fi) 1993-10-25
TW197436B (enExample) 1993-01-01
HU9303025D0 (en) 1994-01-28

Similar Documents

Publication Publication Date Title
CN1100043C (zh) 氨磺酰衍生物和它的制备方法
CN1159311C (zh) 二氢嘧啶类化合物
CN1213022C (zh) 用对称和不对称的取代二苯脲抑制raf激酶
CN1098098A (zh) 哌嗪衍生物
CN1109052A (zh) 嘧啶和吡啶衍生物，它们的生产和应用
CN1261277A (zh) 新的取代咪唑化合物
HK1046134A1 (en) Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
CN1264382A (zh) 新的化合物
CN1073174A (zh) 杂环衍生物
CN1337950A (zh) 2－氧代喹啉化合物及其药物用途
CN1231287A (zh) 苯砜衍生物
CN1075957A (zh) 萘衍生物、其制备方法及其合成中间体
CN1058401A (zh) 抗肿瘤组合物和治疗方法
CN1032361C (zh) 咪唑并哒嗪化合物的制备方法
CN1231472C (zh) 嘧啶无环核苷衍生物、其制备方法及其用途
CN101052634A (zh) 作为vegf受体激酶抑制剂的邻氨基苯甲酰胺吡啶脲
CN1347416A (zh) 取代的3－氰基－[1.7],[1.5]和[1.8]－二氮杂萘酪氨酸激酶抑制剂
CN1066068A (zh) 4-芳基-3-(芳香杂环基脲基)喹啉类衍生物
CN1052478C (zh) 1,4-二取代-5(4h)-四唑啉酮类的制备方法
CN1323306A (zh) 萘啶衍生物
CN87108111A (zh) 一种新颖的咪唑衍生物及其制备方法
CN1359375A (zh) 新的哌嗪基烷硫基嘧啶衍生物、含有它的药物组合物和制备该活性物质的方法
CN1756753A (zh) 苯并呋喃衍生物
CN1328547A (zh) 2,3－二取代的吡啶衍生物、其制备方法、含有其的药物组合物和用于制备中的中间体
CN1942449A (zh) 制备哒嗪酮化合物的方法

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication